Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC, 3695 [2024-00990]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 13 / Friday, January 19, 2024 / Notices
Controlled substance
4-Anilino-N-Phenethyl-4Piperidine (ANPP).
Norfentanyl (N-phenyl-N(piperidin-4-yl)
propionamide).
Drug
code
Schedule
8333
II
8366
II
The company plans to bulk
manufacture the listed controlled
substances for the internal use as
intermediates for formulation and
analytical development purposes. No
other activities for these drug codes are
authorized for this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–00994 Filed 1–18–24; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1310]
Bulk Manufacturer of Controlled
Substances Application: Siegfried
USA, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Siegfried USA, LLC has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before March 19, 2024. Such
persons may also file a written request
for a hearing on the application on or
before March 19, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:42 Jan 18, 2024
Jkt 262001
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on November 28, 2023,
Siegfried USA, LLC, 33 Industrial Park
Road, Pennsville, New Jersey 08070–
3244, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Controlled substance
Gamma Hydroxybutyric
Acid.
Noroxymorphone .............
Hydromorphinol ...............
Amphetamine ..................
Lisdexamfetamine ...........
Methylphenidate ..............
Amobarbital .....................
Pentobarbital ...................
Secobarbital .....................
Codeine ...........................
Oxycodone ......................
Hydromorphone ...............
Hydrocodone ...................
Methadone ......................
Methadone intermediate ..
Morphine ..........................
Oripavine .........................
Thebaine ..........................
Opium tincture .................
Oxymorphone ..................
Tapentadol ......................
Drug
code
Schedule
2010
I
9145
9301
1100
1205
1724
2125
2270
2315
9050
9143
9150
9193
9250
9254
9300
9330
9333
9630
9652
9780
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to bulk
manufacture the listed controlled
substances in bulk for sale to its
customers. No other activities for these
drug codes are authorized for this
registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–00990 Filed 1–18–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF LABOR
Bureau of Labor Statistics
Information Collection Activities;
Comment Request
Bureau of Labor Statistics,
Department of Labor.
ACTION: Notice of information collection;
request for comment.
AGENCY:
The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a pre-clearance consultation
program to provide the general public
and Federal agencies with an
opportunity to comment on proposed
and/or continuing collections of
information in accordance with the
Paperwork Reduction Act of 1995. This
SUMMARY:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
3695
program helps to ensure that requested
data can be provided in the desired
format, reporting burden (time and
financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. The Bureau of Labor
Statistics (BLS) is soliciting comments
concerning the proposed revision of the
International Price Program (IPP) U.S.
Import and Export Price Indexes. A
copy of the proposed information
collection request can be obtained by
contacting the individual listed below
in the ADDRESSES section of this notice.
DATES: Written comments must be
submitted to the office listed in the
Addresses section of this notice on or
before March 19, 2024.
ADDRESSES: Send comments to Nora
Kincaid, BLS Clearance Officer,
Division of Management Systems,
Bureau of Labor Statistics, Room G225,
2 Massachusetts Avenue NE,
Washington, DC 20212. Written
comments also may be transmitted by
email to BLS_PRA_Public@bls.gov.
FOR FURTHER INFORMATION CONTACT:
Nora Kincaid, BLS Clearance Officer, at
202–691–7628 (this is not a toll free
number). (See ADDRESSES section.)
SUPPLEMENTARY INFORMATION:
I. Background
The U.S. Import and Export Price
Indexes, produced by the Bureau of
Labor Statistics’ International Price
Program (IPP), measure price change
over time for all categories of imported
and exported products, as well as
selected services. The IPP has produced
the U.S. Import Price Indexes (MPI)
continuously since 1973 and the U.S.
Export Price Indexes (XPI) continuously
since 1971. The Office of Management
and Budget has listed the Import and
Export Price Indexes (MXPI) as a
Principal Federal Economic Indicator
since 1982. The indexes are widely used
in both the public and private sectors.
The primary public sector use is the
deflation of the U.S. monthly trade
statistics and the quarterly estimates of
U.S. Gross Domestic Product; the
indexes also are used in formulating
U.S. trade policy and in trade
negotiations with other countries. In the
private sector, uses of the Import Price
Indexes include market analysis,
inflation forecasting, contract escalation,
and replacement cost accounting.
The MXPI are closely followed
statistics and are viewed as a key
indicator of the economic environment.
The U.S. Department of Commerce uses
the monthly statistics to produce
monthly and quarterly estimates of
E:\FR\FM\19JAN1.SGM
19JAN1
]]>Agencies
[Federal Register Volume 89, Number 13 (Friday, January 19, 2024)]
[Notices]
[Page 3695]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00990]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1310]
Bulk Manufacturer of Controlled Substances Application: Siegfried
USA, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Siegfried USA, LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
March 19, 2024. Such persons may also file a written request for a
hearing on the application on or before March 19, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on November 28, 2023, Siegfried USA, LLC, 33 Industrial
Park Road, Pennsville, New Jersey 08070-3244, applied to be registered
as a bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............... 2010 I
Noroxymorphone.......................... 9145 I
Hydromorphinol.......................... 9301 I
Amphetamine............................. 1100 II
Lisdexamfetamine........................ 1205 II
Methylphenidate......................... 1724 II
Amobarbital............................. 2125 II
Pentobarbital........................... 2270 II
Secobarbital............................ 2315 II
Codeine................................. 9050 II
Oxycodone............................... 9143 II
Hydromorphone........................... 9150 II
Hydrocodone............................. 9193 II
Methadone............................... 9250 II
Methadone intermediate.................. 9254 II
Morphine................................ 9300 II
Oripavine............................... 9330 II
Thebaine................................ 9333 II
Opium tincture.......................... 9630 II
Oxymorphone............................. 9652 II
Tapentadol.............................. 9780 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances in bulk for sale to its customers. No other activities for
these drug codes are authorized for this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-00990 Filed 1-18-24; 8:45 am]
BILLING CODE P
